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Abstract 29 
 30 
Background: To generate a practical and clinically useful consensus definition of ‘stable glaucoma’ to aid 31 
provision of glaucoma services in the UK and to provide guidance for the criteria that should be used for 32 
monitoring of glaucoma patients in primary care services. 33 
 34 
Methods: A Delphi exercise was undertaken to derive consensus through an online questionnaire. 35 
Participants were asked to score their strength of agreement for a series of clinical parameters. Results 36 
and comments from each round were used to inform subsequent rounds.  A total of 3 rounds were 37 
undertaken. 38 
 39 
Results: 32 glaucoma experts participated in the study with over 90% completion rate achieved over 40 
three rounds. Consensus was reached for the following parameters: IOP levels to be used for defining 41 
stability, visual field-testing techniques to define stability, the number of medication changes acceptable 42 
to define stability and the number of treatment medications allowed to define stability. No consensus 43 
was reached on the period of time over which stability was defined, however there was considerable 44 
agreement that longer durations of follow up (36-48 months) were required. A combination of optic disc 45 
photos and Ocular Coherence Topography (OCT) Retinal Nerve Fibre Layer (RNFL) assessment/ OCT disc 46 
structural evaluation are the preferred imaging methods for the assessment of structural stability.  47 
Oversight by a glaucoma consultant was considered important for glaucoma monitoring schemes. 48 
 49 
Conclusion: The consensus definition of glaucoma stability generated through this Delphi exercise 50 
provides guidance for allocation of patients suitable for monitoring in primary care glaucoma monitoring 51 
schemes. 52 
 53 
 54 
 55 
 56 
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INTRODUCTION  57 
 58 
Over 172,000 referrals for patients with ‘suspect’ glaucoma are made to specialist Ophthalmology 59 
services in England annually, of which an estimated one third require long term follow up. (1) The 60 
referrals for suspect glaucoma in combination with Ocular Hypertension (OHT) account for over 30% of 61 
current ophthalmology outpatient activity. (2) The Royal College of Ophthalmologists (RCOphth) reports 62 
that over the next 20 years glaucoma cases are set to rise by 44%. (3) 63 
 64 
The increasing demand on hospital services has led to the development of alternative community-based 65 
services often run by optometrists for monitoring ‘stable’ and low risk glaucoma patients. (1) (3)NICE 66 
estimates that approximately 56,320 patients out of the 169,500 currently being managed in secondary 67 
care with chronic open angle glaucoma (COAG), suspect COAG and OHT could be managed in the 68 
community. (4) The NICE guidelines for managing glaucoma outline the general principles of monitoring 69 
patients who have, or are suspected of having, COAG or OHT. (4) Intraocular pressure readings with 70 
Goldmann applanation tonometry, assessment of anterior chamber depth, assessment of the optic nerve 71 
head (including imaging) and visual field assessment should all be undertaken.  72 
 73 
Despite the move to commission a greater number of community services for the monitoring of OHT and 74 
suspect glaucoma, (1) there is no established consensus on the clinical definition of ‘Stable Glaucoma’ 75 
currently available in the literature. This definition is left to the discretion of local service providers and 76 
so it is likely that there is inconsistency in how patients are monitored in these community-based clinics. 77 
A definition of ‘stable glaucoma’ would not only inform the effective design and commissioning of 78 
glaucoma services in the NHS by identifying those patients who can safely be monitored outside a 79 
secondary care environment, but also contribute to developing standards for these patients to be 80 
managed safely within the community and aid in accurately identifying those who need to be re-referred 81 
back to secondary care allowing consistent delivery of glaucoma services.  82 
 83 
The aim of this study is: 84 
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1. To establish a consensus on the definition of “stable” glaucoma amongst consultant 85 
ophthalmologists with a recognised expertise in glaucoma. 86 
2. To evaluate which factors are important when discharging ‘stable glaucoma’ patients to 87 
different oversight models of community-based care. 88 
 89 
METHOD 90 
 91 
An expert panel, consisting of Ophthalmology consultants with glaucoma subspecialist interest in the UK, 92 
were consulted in an adapted (3-round) Delphi exercise (5) (6) (7) to establish consensus on the definition 93 
of stable glaucoma.  94 
We approached 33 of the 150 glaucoma specialists registered with the RCOphth. The group was a 95 
representative mix of teaching and district general hospital consultants and geographical distribution 96 
within the UK. The experts were identified via their membership of the UK and Eire Glaucoma Society 97 
and initially approached via an email which described the purpose of the exercise. Thirty-two responded 98 
to confirm their interest in participating and this was deemed to be an appropriate number of 99 
respondents to undertake a valid Delphi process. They were provided with further information about the 100 
survey and were subsequently involved in the Delphi process. No incentives were offered to participants. 101 
Prior research has suggested that a panel with a minimum of twelve members is required for the findings 102 
of a Delphi exercise to be considered valid. (5) 103 
 104 
The University of Nottingham School of Medicine Ethics committee confirmed that this consultative 105 
survey did not require ethical approval.  106 
 107 
The survey process was managed using the online survey tool Survey Monkey with each questionnaire 108 
designed to take around 15 minutes to complete. Participants were sent a personalised link to the 109 
questionnaires and asked to indicate their strength of agreement for each of a series of parameters using 110 
a 0-10 scoring scale, where 10 indicated strong agreement and 0 strong disagreement.  111 
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 112 
The clinical parameters examined in this way were:  113 
1. Time Period:  How long should a patient be monitored before being considered stable. 114 
2. Visual Field Methods: Which Visual field (VF) assessment methods should be used to define 115 
stability. 116 
3. Imaging Methods: Which imaging assessment methods should be used to define stability. 117 
4. Intra-ocular pressure (IOP): What IOP level should be used to define stability? 118 
5. Use of drops: Whether the total number of IOP lowering agents drops being used by a patient 119 
or a change in number of drops required should be used to define stability.  120 
6. Consultant Oversight: the nature and clinical expertise of the consultants overseeing patients 121 
within community monitoring services.  122 
 123 
After each round scores were synthesised and descriptive statistics for all (whole group) responses were 124 
generated for each parameter. A group median score 8-10 was considered to indicate ‘strong agreement’ 125 
with a parameter; a median score 0-2 strong disagreement. The use of median scores to summarise 126 
group responses in this way is common in Delphi research (7) however, median scores in isolation may 127 
disguise a broad range of scores which might be typical of panel disagreement. To counter this and to 128 
add rigour to our Delphi process, we combined a median score with an Interquartile Range (IQR) 129 
assessment (6) (7) (8) (9). An IQR score indicates the concentration of scores across the range of scoring 130 
options; an IQR of 2 indicates that 50% or more of responses are within 1 score of the median, an IQR 131 
of 8 indicates that scores are more broadly dispersed. To be confident that agreement about parameters 132 
had been reached we defined consensus as: a median score indicating strong agreement (8-10) or strong 133 
disagreement (0-2) in combination with an IQR of 2 points or less (demonstrating a concentration of 134 
scoring around the median). In all other circumstances, less strong agree/disagree (median 3-7) or 135 
dispersed scoring (IQR>2), consensus was not considered to have been reached. 136 
 137 
Alongside scoring, participants were given the opportunity to offer free-text comments which might 138 
contextualize or explain their responses.  139 
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 140 
Those parameters where scoring demonstrated consensus amongst the expert panel were either 141 
accepted as a characteristic of stable glaucoma, or rejected from our process. These parameters were 142 
fixed and not scored in subsequent survey rounds.   143 
 144 
Where consensus was not achieved, parameters were amended (in accordance with previous scoring 145 
and any relevant free-text comments) in such a way as to support the generation of consensus. For 146 
example, the duration of time for monitoring stable glaucoma was increased to support the generation 147 
of panel agreement about it. Revised parameters, along with summary scores from previous rounds and 148 
any indication of changes to the parameter, were included in the next iteration of the survey for scoring. 149 
 150 
This process was repeated twice in this amended, 3-round Delphi exercise. In the final round, for 151 
parameters where consensus was not established, participants were asked to rank options in an attempt 152 
to find a weaker form of agreement about a parameter. Also in the final round an additional question, 153 
quantifying visual field progression in stable glaucoma, was added to further our understanding of Visual 154 
Field stability. 155 
 156 
RESULTS 157 
 158 
In round 1 there were 32 responses (100%), 31 in round 2 and 29 in round 3, giving a final response rate 159 
of 90.63%. (10) Out of the 21 questions in which a consensus was reached, 10 out of 21 questions reached 160 
consensus in the first round, 7 in round two and 4 in round three (Figure1). The results for each clinical 161 
parameter are presented in Table 1. 162 
 163 
Strong agreement consensus was achieved that visual field stability should be assessed by trend analysis 164 
or by summary measures of VFI/ MD progression. Other methods of assessment or combinations of 165 
assessment methods did not reach consensus agreement.  166 
 167 
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The supplementary question (scored 1 – 4) to quantify the amount of visual field progression (MD) that 168 
can be defined as ‘stable’ found strong agreement on 0dB of change being stable (M4) and <4dB being 169 
unstable (M1) with stability scoring decreasing with greater change in MD. (<1dB:M3, <2dB:M2).  170 
 171 
Strong consensus agreement was reached on the following (Figure 2):  172 
 IOP level used to define stability should be based on a clinician defined target IOP tailored for 173 
individual patients  174 
 Having no drop treatment change during the stability assessment period is considered stable 175 
 An increasing number of drop changes indicates instability (3 drop changes for the optimisation 176 
of IOP control during the stability assessment period is not considered ‘stable’) 177 
There was no consensus on the number of agents used for the optimisation of IOP when defining stability 178 
and ‘The number of agents required for the optimisation of IOP control is not important for defining 179 
glaucoma stability’ (M0, IQR0) (Figure 3)  180 
 181 
No consensus was reached on what method or combination of imaging techniques, should be used to 182 
define structural glaucoma stability. In round 3 when respondents were asked to rank combinations of 183 
methods in order of preference, the combination of Optic disc (OD) photos (including stereoscopic disc 184 
photos) and OCT RNFL assessment was the most preferable followed by the combination of OD photos 185 
and OCT disc structural evaluation, with the combination of OCT RNFL assessment and OCT structural 186 
evaluation being the least preferred.  187 
 188 
No consensus was achieved for length of the monitoring period required to define stability for patients 189 
identified with ‘high’ and ‘low’ risk glaucoma.  There was a trend of increasing agreement with longer 190 
time periods of 36 and 48 months. This is illustrated in Figure 4a and 4b.  191 
 192 
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For independent community glaucoma monitoring schemes run by optometrists with Higher Certificate 193 
Glaucoma A or Glaucoma B or level III or IV qualifications (2) there was strong agreement consensus that 194 
they should be overseen by consultants with glaucoma speciality expertise. 195 
 196 
For all community scheme models: (1) without consultant overview, (2) overseen by general 197 
ophthalmologists and (3) overseen by a consultant with glaucoma expertise – there was strong consensus 198 
agreement that an assessment of glaucoma stability should be made before patients are transferred to 199 
a glaucoma-monitoring scheme and that only patients with “stable” glaucoma should be transferred to 200 
these schemes. Severity and type of glaucoma were regarded important factors to consider when 201 
discharging patients to a community-based monitoring scheme. There was no consensus on the 202 
importance of considering a patient’s age unless referring patients to a service with no consultant 203 
overview, when it is deemed important.  204 
 205 
DISCUSSION  206 
 207 
Currently there is no definition of ‘stable glaucoma’ and there has been no previous attempt to generate 208 
a consensus definition of ‘stable glaucoma’. The Delphi method originated in the 1950s when the US Air-209 
Force commissioned the RAND project to reach a consensus amongst military experts. (11) It has since 210 
become an established method of consensus development in the health field and has specifically been 211 
used to establish consensus in the field of glaucoma in multiple settings from developing standards for 212 
glaucoma virtual clinics (12) to developing specifications of open angle glaucoma screening interventions 213 
in the United Kingdom. (13) (14) (15) (16) 214 
 215 
The method focuses on measuring the consensus of a group of qualified participants and has 216 
demonstrated decision-making advantages over other traditional methods, (17) allowing for the 217 
discussion of complex problems whilst giving participants sufficient time to respond at their own 218 
convenience.  219 
 220 
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It has been established that the selection of the participants is likely to have little impact on the group 221 
decision as long as the selection reflects the range of experience and characteristics of the population 222 
from which the participants are selected. (18)  It is not possible to make any definite statement about 223 
whether similar groups will produce similar/ the same results.  Having less than six participants has low 224 
reliability and with large groups (above twelve) the increase in reliability needs to be balances with 225 
diminishing return rates. (5) Thus, reliable outcomes can be obtained with a relatively small Delphi panel 226 
size with a response rate of over 70%. (10)  227 
 228 
Taking this into account, our panel of 32 respondents and our response rate of over 90% on the definition 229 
of ‘stable glaucoma’ carries weight for the formation of clinical guidelines. Consensus was reached on 230 
the majority of key clinical parameters and where consensus was not reached there was a strong 231 
consensus trend. We have used the consensus agreement obtained to generate a definition of stable 232 
glaucoma as follows:  233 
 234 
1) IOP control should be below a target defined by the patients’ clinician – This ensures a tailored 235 
approach for each patient and allows clinicians to incorporate important factors such as age, 236 
presenting IOP, extent of visual field loss and known rate of visual field progression into this 237 
target. (19) (20) 238 
2) Visual field loss can be monitored by Visual field testing with trend analysis of VFI/ MD 239 
progression – This represents a simple and practical method of assessing visual field progression 240 
used in standard clinical practice.  It is no surprise that 0 dB of change is considered stable as 241 
essentially this indicates no change.  Questioning if clinicians were comfortable with small 242 
amounts of visual field loss in the context of stability we found that as larger changes in VF loss 243 
are suggested - these changes are considered progressively unstable.  244 
3) No change to the medication regime indicates stability  245 
We were unable to generate a consensus on length of time required to define stability, but our data 246 
suggests assessment of stability should take place over an extended period of time at least 36-48 247 
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months. The lack of consensus on the exact duration of follow-up required before glaucoma can be 248 
defined as stable may be a reflection of nervousness amongst clinicians in considering glaucoma a 249 
stable disease, as one respondent commented – “glaucoma is by definition a progressive condition and 250 
may progress at any time during the patients’ lifetime, even after it has been stable for many years”. 251 
Lack of Delphi consensus on imaging techniques may indicate that when considered on their own, no 252 
single imaging technique is currently seen as sufficient or reliable for indicating stability, this may change 253 
with the development of improved technologies. However, when asked to rank the available options the 254 
combination of OD photos and OCT RNFL assessment/ OCT disc structural evaluation were the preferred 255 
imaging methods for the assessment of structural stability. (21) Again this may indicate unease with 256 
relying on a single technology at present and a move towards the use of multimodality imaging when 257 
organising a monitoring service.  258 
 259 
Based on the findings of this Delphi process, we suggest that the following could be used as a practical, 260 
working definition of stable glaucoma:  261 
 262 
Glaucoma may be defined as “stable” when the IOP remains below the target IOP defined by the 263 
patients’ clinician, on less than three medications and requiring no medication changes over a 48-month 264 
period during which no further visual field loss monitored by Visual field testing with trend analysis of 265 
VFI/ has occurred.  266 
 267 
The aim of this project was to identify a consensus agreement for defining stable glaucoma to allow 268 
patient entry into ‘stable glaucoma’ monitoring schemes and to determine the oversight that would be 269 
necessary to run different models of such schemes. 270 
 271 
Despite current governance around community glaucoma schemes and Glaucoma certificates, the 272 
consensus was that all community glaucoma monitoring schemes should be overseen by consultant 273 
ophthalmologists with glaucoma speciality expertise and it is not acceptable to have no consultant 274 
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overview of the scheme. This may seem counter intuitive in the context of established recognised higher-275 
level qualifications for optometrists which acknowledge their expertise in the assessment and 276 
management of glaucoma and the development of prescribing qualifications which allow optometrists 277 
to actively treat patients – however, the consensus may simply reflect consultants erring on the side of 278 
caution and it may be that with time, as these schemes become more established and integrated into 279 
the continuous model of care  - this attitude will change. 280 
 281 
The decision of when to transfer patients to a community monitoring scheme varies between regions, 282 
some involving clinician’s acumen, others a set of criteria given by the community provider or a 283 
combination of the two. The criteria for monitoring and referral back to Hospital Eye Services (HES) is a 284 
generally not clear and reliant on the internal governance of community providers.  285 
 286 
In our survey, there was consensus that an assessment of glaucoma “stability” should be made prior to 287 
transferring patients to community glaucoma monitoring schemes and only patients who are considered 288 
“stable” should be transferred. The use of our definition of glaucoma stability will increase consistency 289 
and transparency within glaucoma service provision. 290 
 291 
Other important factors to consider on discharge include: glaucoma diagnosis, severity and the patients’ 292 
age. It is interesting that regardless of the level of oversight for the community scheme, there was little 293 
difference in the results for each parameter.  294 
When assessing patients within the community monitoring schemes, the key is to identify patients who 295 
are stable and those who do not meet the parameters of stability. Patients who are not stable need to 296 
be referred back to HES for further management and intervention. Our consensus definition helps to 297 
refine this process by providing some parameters of stability which are important regardless of the level 298 
of oversight supporting a particular scheme model. 299 
 300 
Limitations 301 
 302 
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Ensuring confidentiality is an important aspect of formal consensus development. However, the Delphi 303 
method can be criticised for losing the benefits of face-to-face interaction which other forms of 304 
consensus development such at the nominal group technique (NGT) allow. Although the NGT may have 305 
enabled a more sophisticated and nuanced consideration of stable glaucoma, it places a greater time 306 
demand upon participants and rests upon all members of an expert group being able to attend an 307 
extended meeting (a full day) - It is hard to imagine that we would have been able to achieve this with 308 
the 32 glaucoma specialists. 309 
 310 
The survey sample of Ophthalmology consultants was selected from registered Glaucoma Specialist 311 
Consultants who are recognised as authorities in the clinical aspects of glaucoma. However, many 312 
clinicians who are non– glaucoma specialists and health care professionals with glaucoma expertise are 313 
involved in the delivery of Glaucoma services and further study of their understanding and consensus of 314 
the parameters which are used to define stability is warranted.  315 
 316 
It could be argued that there is a potential for bias in asking consultant ophthalmologists with glaucoma 317 
speciality expertise whether their oversight is important in running stable glaucoma monitoring schemes.  318 
However, for a consensus exercise it is appropriate to approach those most knowledgeable in a specific 319 
field in this case glaucoma for their expert opinion. This consensus outcome can then be used to inform 320 
both specialist and non-specialist of consensus driven best practise.  At present, many general 321 
ophthalmologists manage this patient cohort already and there are established optometry–led glaucoma 322 
clinics managing stable glaucoma within the hospital setting without sub-specialist ophthalmic oversight.  323 
This consensus outcome will further inform the future structure of such services.    324 
 325 
We are unable to address this possibility directly, however there is a recognition that glaucoma 326 
consultants are already overwhelmed and insufficient in numbers to provide a service sufficient to meet 327 
the needs of the aging population (3) and unlikely therefore to want to continue to contribute to a service 328 
that they did not believe requires their oversight. Further exploration of this would be helpful and seeking 329 
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opinion of non-ophthalmologists would clarify whether this opinion is shared by other health care 330 
professionals providing glaucoma care.  331 
 332 
CONCLUSION 333 
 334 
We believe this study has achieved a practical, multifactorial consensus definition of “stable” glaucoma 335 
for evaluation of transfer of patients to primary care glaucoma monitoring schemes and a consensus that 336 
all such schemes should have glaucoma consultant oversight. This will aid planning and allow consistent 337 
modeling of future primary care glaucoma monitoring schemes. 338 
 339 
 340 
 341 
 342 
 343 
 344 
 345 
 346 
 347 
 348 
 349 
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